Latest Data


« Update Researchers Improve Accuracy Of Breast Cancer Prognoses | Main | New Entry Blood Test Detects Ovarian Cancer Early (reuters) »

Subject Genvec Presents Encouraging Data On Tnferade(tm) In Esophageal Cancer

By admin2 | June 25, 2008

MedicalGenVec, Inc. (Nasdaq:GNVC) presented an overview of TNFerade™ development and an update on long-term survival data from its Phase II clinical trial using TNFerade in patients with esophageal cancer at the American Society of Gene Therapy (ASGT) 11th Annual Meeting in Boston, MA. Dr.
(Link)

This entry was important to me: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • StumbleUpon
  • Digg
  • del.icio.us
  • Reddit
  • Furl
  • Junipo

Topics: Cancer |

Comments